Akebia Therapeutics (AKBA) Enterprise Value (2014 - 2026)
Akebia Therapeutics' Enterprise Value was $154.24 million in Q2 2026, down 81.2% from $820.16 million a year earlier and down 26.5% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Enterprise Value (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Akebia Therapeutics' Enterprise Value was -$359.69 million through Jun 30, 2026; for FY2025, it was $242.49 million, down 35.4% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 5.5% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $375.34 million in FY2024 (+89.2%), $198.36 million in FY2023, $16.33 million in FY2022 (-93.5%) and $250.22 million in FY2021 (+34.6%).
- The Q2 2026 figure marks the lowest quarterly Enterprise Value since Q2 2023.
- Compared with a year earlier, Enterprise Value has declined for three straight quarters, with growth averaging 60.4% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2024 (growth of 625.1%); the worst was Q4 2022 (a decline of 93.5%).
- Per Business Quant data, AKBA's Enterprise Value in the three quarters before Q2 2026 was $209.73 million (Q1 2026), $242.49 million (Q4 2025) and $557.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154.24 Mn |
| Mar 31, 2026 | 209.73 Mn |
| Dec 31, 2025 | 242.49 Mn |
| Sep 30, 2025 | 557.62 Mn |
| Jun 30, 2025 | 820.16 Mn |
| Mar 31, 2025 | 388.96 Mn |
| Dec 31, 2024 | 375.34 Mn |
| Sep 30, 2024 | 245.22 Mn |
| Jun 30, 2024 | 174.63 Mn |
| Mar 31, 2024 | 341.30 Mn |
| Dec 31, 2023 | 198.36 Mn |
| Sep 30, 2023 | 168.15 Mn |
| Jun 30, 2023 | 119.48 Mn |
| Mar 31, 2023 | 47.07 Mn |
| Dec 31, 2022 | 16.33 Mn |
| Sep 30, 2022 | -85.94 Mn |
| Jun 30, 2022 | -79.60 Mn |
| Mar 31, 2022 | -42.56 Mn |
| Dec 31, 2021 | 250.22 Mn |
| Sep 30, 2021 | 295.51 Mn |
API Access
Akebia Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();